That is necessary, since the method a protein in the human body folds identifies if a pharmaceutical will have the ability to bind to that protein and work. To put it simply, we need to know how these proteins fold if we want a drug to work. Historically, this has been a trial-and-error process (biotech stocks jeff brown). Now, Alpha, Fold can predict protein folding with 92. 4% accuracy. That's going to make it a lot easier to develop drugs that do what they're created to do. This was an advancement almost no one observed. However it's going to have profound ramifications for curing disease. I forecast that Alpha, Fold will be 98% precise by the end of 2021.
And, naturally, there will be a lot of investment chances in this space, too. Shifting subjects It's going to be a great year for bitcoin. I'm bullish on it in 2021 (second wave). That stated, I still think bitcoin will continue to be unstable. We're close to all-time highs. I wouldn't be amazed if it pulled back perhaps considerably before going higher - future report review. I've been covering bitcoin for a very long time now. One of the very first research study reports I ever published was on bitcoin. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $34,000 today.
But at the time of that initial suggestion, I entitled my report "What's the Big Deal With Bitcoin?" That reveals you where the conversation was at the time. We were mainly informing readers. However that's not the big question anymore. Now we're seeing institutional money lastly take an interest in bitcoin. Massachusetts Mutual Life Insurance coverage took a $100 million stake in bitcoin in December. This is not some small, specific niche enterprise. Mass, Mutual is a trusted 170-year-old organization. So consider that. In 5 years, we went from informing readers on what bitcoin is to a business like Mass, Mutual taking a $100 million stake.
Which's a big factor I'm bullish on it this year. tech stock. Regards, Jeff Brown, Editor, The Bleeding Edge I have a perk forecast 2020 was a record year for IPOs. 552 U.S. business went public the most in more than twenty years. These business raised an overall of $172 billion. That's an all-time high beating the previous yearly record by 43%. I anticipate 2021 will be another record year in IPOs. There are numerous fantastic personal business on the brink of hitting the public markets And I've been dealing with a brand-new method for you to invest even prior to these business go public.
This opportunity has been developing over the last few years. I can't wait to inform you all about it. Join me tomorrow at 8 p. m. ET for my Pre-IPO Code Event to discover all the details. Go right here to reserve your spot free of charge.
Emma Walsh here, handling editor of the Diary. Routine Journal readers understand that tech isn't our typical beat (jeff brown investor prediction). And when it comes to tech investing, we leave it to the specialists. Thankfully, we have numerous such professionals in our Rolodex. Our associate Jeff Brown will recognize to our longtime readers. He is one of the most accomplished tech investing experts we know (biotech stock). In reality, he had numerous triple-digit returns in his Brownstone Research portfolios in 2015. Here's what Jeff believes the tech sector will bring us in 2021 Each year, I like to take a look at the huge image and anticipate what's just around the corner.
That includes things like 5G networks, biotech, artificial intelligence, and far more. These patterns are experiencing rapid growth and creating extraordinary chances for investors. I want to make certain all our readers are prepared for what's next. And with that in mind, let me draw the picture of what I see coming in the next 12 months Our brand-new 5G (fifth-generation) wireless networks are a topic I've been covering for years now. jeff brown biotech genome sequencing. However in spite of what numerous readers may believe, this is a pattern that's just starting. Even though the COVID-19 pandemic interrupted supply chains last year, a remarkable 250 million 5G-enabled devices were still sold.
And all of this ultimately led to Apple postponing the release of the 5G-enabled i, Phone 12 by 2 months (democratic republic). Losing two months of manufacturing and sales really impacts the number of 5G gadgets are sold in the fiscal year. When you think about all of that, offering 250 million systems is remarkable. More significantly, the hold-ups brought on by the pandemic created a lots of suppressed need. Which demand is now going to be pushed into 2021. In truth, I forecast that more than 500 million 5G gadgets will be shipped in 2021 - tech predictions. Which's not my only 5G forecast When I have actually spoken about 5G in the past, I have actually explained its three different stages.
In Stage Two, 5G devices go on sale. 5G phones and other products begin to reach customers. And in Phase Three, 5G services start to be provided (tech stocks). That's when we start to see applications operating on 5G networks. Think of things like enormous multiplayer games over a cellphone. That's not possible with 4G. It will be with 5G. And my 2nd 5G prediction for 2021 is that we will start Stage Three by this summer season. This starts something of a virtuous cycle: The majority of people don't truly care about the technology. But they will care if there are amazing applications that can only be accessed with a 5G phone.
That results in more 5G apps being established. In fact, 5G is going to open a suite of amazing applications: self-driving cars, the Internet of Things, robotic surgical treatment, and more. All of these technologies require 5G. The financial investment opportunities moving forward will be enormous. Stepping away from 5G, the next crucial technology I visualize in 2021 is CRISPR genetic editing. CRISPR represents "clustered regularly interspaced brief palindromic repeat." It's a mouthful. But it's one of the most interesting advancements in biotechnology. At a high level, CRISPR is a technology that can edit our genetic makeup as if it were software application.
The program can crash or not function properly. CRISPR utilizes a comparable concept however with our genetic code. "Typos" in our genome can cause disease. CRISPR can correct these "typos." For many years, CRISPR was mostly a specific niche technology that wasn't well comprehended. And during that time, there were really just three business operating in this space. However things are changing. CRISPR is no longer just theoretical. We're seeing real outcomes. We're treating diseases and seeing that this technology just works. And as an outcome, a "second crop" of early-stage CRISPR business is going public and delivering unbelievable returns. This whole industry is efficiently a greenfield chance.
There's space for many companies to exist in this area. jeff brown 1 biotech company. And there will be more. That's my prediction for CRISPR in 2021. I anticipate that 2 or three more hereditary modifying companies will hold their IPOs. Sticking with biotechnology, we are seeing amazing things taking place at the convergence of biotech and synthetic intelligence (AI). Google's AI subsidiary, Deep, Mind, just revealed at the end of 2020 that its latest Alpha, Fold software application can properly forecast the folding of a protein based solely on its amino acid sequence with 92. 4% precision. That is necessary because the method a protein in the human body folds identifies if a pharmaceutical will be able to bind to that protein and be efficient.
Historically, this has actually been a trial-and-error procedure. Now, Alpha, Fold can anticipate protein folding with 92. 4% accuracy. That's going to make it much easier to produce drugs that do what they're created to do. And here's my next prediction. I anticipate that Alpha, Fold will be 98% accurate by the end of 2021. And we will see not just one but several drug therapies produced using this technology. This was one of those breakthroughs that nearly no one noticed. However it's going to have extensive ramifications for treating disease. And, of course, there will be a lot of financial investment chances in this space, too.
It's going to be a great year for bitcoin. I'm bullish on it in 2021. That stated, I still believe bitcoin will continue to be unstable. We're close to all-time highs. I would not be amazed if it pulled back possibly significantly before going greater. I have actually been covering bitcoin for a long period of time now. Among the first research study reports I ever published was on bitcoin - melania trump. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $40,000 today. So that's a 16,500%+ return on financial investment for anyone who followed my suggestion. However at the time of that initial suggestion, I entitled my report, "What's the Big Offer With Bitcoin?" That shows you where the conversation was at the time.
But nobody is asking that concern any longer. Now, we're seeing institutional money lastly taking an interest in bitcoin. The huge news was that Massachusetts Mutual Life Insurance coverage took a $100 million stake in bitcoin in December. This is not some little, specific niche business. tech predictions. Mass, Mutual is a 150-year-old institution. So consider that. In five years, we went from educating readers on what bitcoin is to a business like Mass, Mutual taking a $100 million stake. The institutional adoption of bitcoin will continue. And that's a big factor why I'm bullish on it this year. Regards, Jeff Brown, Editor, The Bleeding Edge I have one more bonus prediction In 2021, we're going to have another record year in IPOs. One site reports that Jeff Brown deserves about $27. 5 million and declares the information depends on date since February 2021, however we could not separately confirm this claim. Provided Jeff Brown's past, he likely has a considerable net worth, however we can't hammer down a precise figure at this moment. Brown is best understood for his sage-like ability to choose winning technology stocks. He invested more than 25 years looking into technology business like Qualcomm, NXP semiconductors, and Juniper Networks. Brown's substantial experience provides him an outstanding viewpoint on the market. He's constantly on the hunt for new chances, and he shares numerous of his finest picks in the Near Future Report.
That's high praise, but it's not absurdly reasoned. Brown has an outstanding reputation as a stock-picker, and he successfully predicted a few of the most significant economic occasions of the past 20 years. Although he doesn't appear to launch his choices to the general public, the service's success is a direct indicator of Brown's stock-picking expertise. No one on Wall Street gets it best whenever, but Jeff Brown's precise predictions have actually earned him legions of devoted followers. That states a lot about his ability. The Near Future Report is published by Brownstone Research, a popular monetary research study publisher. Brownstone Research provides numerous research services with a broad range of specializations - diplomatic relations.
The business is likewise connected with Bonner & Partners, another well-respected research publisher - artificial intelligence. On its site, Brownstone says its objective is to provide retail financiers with professional-grade research: "For too long, the very best investment research has actually not been offered to private investors. It has actually been usually scheduled for investment banks, hedge funds, private equity, and high-net-worth clients. self-driving cars. The mission of Brownstone Research study is to make that kind of exclusive research study offered to any financiers seeking to acquire an edge in the marketplaces. The goal is simple to provide distinct and rewarding investment research discovered nowhere else." -Brownstone Research website excerpt from the Jeff Brown is the creator of Brownstone Research study, and he likewise functions as the company's Chief Investment Expert.
With Brown assisting the ship, Brownstone Research study is a powerhouse publisher with lots to provide its customers. After decades of steady success at the helm of top-tier business like Tesla and Area, X, Elon Musk is a household name throughout the majority of America. If you understand even a bit about the market, you understand that he has a reputation as a King Midas of sorts. korean actress. Whatever he touches turns to gold! Jeff is aware of Elon Musk's executive expertise, so he always has an eye out for the Silicon Valley rock star's next relocation. This time, Jeff has an early lead on Elon's next huge job.
In reality, Brown believes S.A.V. united states. could be "the greatest pattern of the 2020s, and he's not alone. Take a look at these quotes from other widely known S.A.V. bulls: Elon's next big act will be marrying 2 cutting-edge innovations: expert system and electric automobiles. Musk hopes the mix will help him develop the first fully-autonomous, self-driving automobiles ever. It's absolutely nothing except the vehicle market's Holy Grail. As you understand, electric cars and self-driving vehicle stocks have actually been huge this year, however the Wall Street device has actually been huge on hype without much concrete outcome. Despite an extreme increase in competitors over the past few years, Brown still thinks Musk has the best chance of putting it all together.
tech could be the magic string that ties everything together. S.A.V. stands for Shared Autonomous Car, and it could be the future of transportation. Essentially, this innovation would enable you to lease your vehicle as a self-governing, self-driving taxi when you're not using it. You merely get out of the cars and truck and press a button on an app that informs the car to "join the fleet." Next thing you know, you're unwinding on your couch while your cars and truck shuttles ride-sharers around town. Most importantly, you get to keep a large piece of the profits. It sounds outrageous, however it might be closed than you think.